Tesla shares outperformed the broad market on Friday, with the stock closing up 0.33% to close just under $760. This was a strong performance when you look at the broad market, which fell nearly 1%. Cathy Wood is still selling Tesla but this has failed to dent investor enthusiasm for the stock. Friday was actually quiet enough in the name, with the range around $10 dollars, this despite quadruple witching. The stock remains bullish but is slowly grinding higher, frustrating many. The short-term target is set above $740, break $760 quickly and then rally past $780. Protagonist Therapeutics, Inc. PTGX +62.48% shares tumbled 63% to $17.30 after the company reported the FDA placed a clinical hold on rusfertide development program. Shares of TCR2 Therapeutics Inc. TCRR +35.21% were down 35% to $10.24 after the company announced interim results from an ongoing Phase 1/2 trial of gavo-cel for the treatment of refractory mesothelin-expressing solid tumors.

BULLISH AND BEARISH CONDITIONS/ POSSIBILITIES :

The leading and lagging sectors affecting the performance of NAS100 with there outcomes are Health care shares slipping by just 0.1% on Friday. Meanwhile, top gainers in the sector included Innate Pharma S.A. IPHA +undefined% (Get Free Alerts for IPHA), up 47% and Larimar Therapeutics, Inc. LRMR +undefined% (Get Free Alerts for LRMR) up 19%. From the technical point of view, NAS100 is standing near exponential moving average 50 in daily at 15148 which can become a point of bullish reversal on the chart but a move down further would lead the indice towards our next major support i.e 14717 where we have our 61.8% fibb retracement level is situated. 

NAS100

Sep 20 2021

4